DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
What is the competitive landscape for MYLAN PHARMS INC, and when can generic versions of MYLAN PHARMS INC drugs launch?
There are eleven US patents protecting MYLAN PHARMS INC drugs. There are twenty-nine tentative approvals on MYLAN PHARMS INC drugs.
There are one hundred and ninety-one patent family members on MYLAN PHARMS INC drugs in thirty-nine countries and four hundred and fourteen supplementary protection certificates in thirteen countries.
Summary for Mylan Pharms Inc
| International Patents: | 191 |
| US Patents: | 11 |
| Tradenames: | 201 |
| Ingredients: | 191 |
| NDAs: | 245 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 200477-003 | Nov 30, 2015 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Pharms Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 070791-002 | May 13, 1986 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Pharms Inc | ACYCLOVIR | acyclovir | TABLET;ORAL | 075211-001 | Sep 28, 1998 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Mylan Pharms Inc | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | candesartan cilexetil; hydrochlorothiazide | TABLET;ORAL | 090704-001 | Dec 4, 2012 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | ZOVIRAX | acyclovir | CAPSULE;ORAL | 018828-001 | Jan 25, 1985 | 4,199,574 | ➤ Try a Free Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ➤ Try a Free Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ➤ Try a Free Trial |
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for MYLAN PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Foam | 0.12% | ➤ Subscribe | 2007-08-10 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Topical Foam | 0.05% | ➤ Subscribe | 2005-06-27 |
Non-Orange Book US Patents for Mylan Pharms Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 5,684,153 | Process for the preparation of purine derivatives | ➤ Try a Free Trial |
| 8,586,066 | Topical antifungal composition | ➤ Try a Free Trial |
| 8,449,867 | Microemulsion and sub-micron emulsion process and compositions | ➤ Try a Free Trial |
| 7,749,488 | Pharmaceutical foam | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Mylan Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Denmark | 8504246 | ➤ Try a Free Trial |
| Argentina | 082432 | ➤ Try a Free Trial |
| Morocco | 22051 | ➤ Try a Free Trial |
| Germany | 3485225 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mylan Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB03/034 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313 |
| C0007 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: SILDENAFIL, NATL REGISTRATION NO/DATE: EU/1/98/077/001 19980914; FIRST REGISTRATION: CH 54642 19980622 |
| /1998 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ''IRBESARTAN'' UND DESSEN PHARMAZEUTISCH ANNEHMBAREN SALZE; NAT. REGISTRATION NO/DATE: EU/1/97/046/001 - EU/1/97/046/009 19970827; FIRST REGISTRATION: LI 5425002 19970815 |
| /2000 | Austria | ➤ Try a Free Trial | PRODUCT NAME: EFAVIRENZ, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES; NAT. REGISTRATION NO/DATE: EU/1/99/110/001-004 1/99/111/001-004 19990528; FIRST REGISTRATION: LI 54908 01, 54908 02, 54908 03 19981120 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
